Mukka Proteins [MUKKA] vs BN Holdings [BNHOLDINGS] Detailed Stock Comparison

Mukka Proteins Ltd.

NSE
Loading...

BN Holdings Ltd

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Mukka Proteins Ltd. wins in 9 metrics, BN Holdings Ltd wins in 10 metrics, with 0 ties. BN Holdings Ltd appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Mukka Proteins Ltd. BN Holdings Ltd Better
P/E Ratio (TTM) 15.95 26.71 Mukka Proteins Ltd.
Price-to-Book Ratio 1.58 5.01 Mukka Proteins Ltd.
Debt-to-Equity Ratio 131.93 21.23 BN Holdings Ltd
PEG Ratio -1.56 -0.13 BN Holdings Ltd
EV/EBITDA 11.91 71.58 Mukka Proteins Ltd.
Profit Margin (TTM) 3.11% 8.31% BN Holdings Ltd
Operating Margin (TTM) 6.34% 11.63% BN Holdings Ltd
EBITDA Margin (TTM) 6.34% 11.63% BN Holdings Ltd
Return on Equity 10.18% 5.05% Mukka Proteins Ltd.
Return on Assets (TTM) 4.32% 2.98% Mukka Proteins Ltd.
Free Cash Flow (TTM) $-1.39B $-315.40M BN Holdings Ltd
1-Year Return -26.27% 121.74% BN Holdings Ltd
Price-to-Sales Ratio (TTM) 0.50 6.91 Mukka Proteins Ltd.
Enterprise Value $12.94B $39.47B BN Holdings Ltd
EV/Revenue Ratio 0.89 7.85 Mukka Proteins Ltd.
Gross Profit Margin (TTM) 13.19% 12.89% Mukka Proteins Ltd.
Revenue per Share (TTM) $48 $117 BN Holdings Ltd
Earnings per Share (Diluted) $1.50 $13.31 BN Holdings Ltd
Beta (Stock Volatility) 0.17 0.63 Mukka Proteins Ltd.

Mukka Proteins Ltd. vs BN Holdings Ltd Stock Performance Analysis

Loading Price Chart...

MUKKA
BNHOLDINGS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Mukka Proteins Ltd.-2.18%-3.64%-8.54%0.73%-13.71%-8.73%
BN Holdings Ltd-6.39%-2.61%-5.30%22.11%136.19%246.30%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Mukka Proteins Ltd.-26.27%-46.06%-46.06%-46.06%-46.06%-46.06%
BN Holdings Ltd121.74%678.57%678.57%678.57%678.57%678.57%

Performance & Financial Health Analysis: Mukka Proteins Ltd. vs BN Holdings Ltd

MetricMUKKABNHOLDINGS
Market Information
Market Cap i₹7.18B₹38.60B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i303,01912,011
90 Day Avg. Volume i307,22915,565
Last Close₹21.96₹378.85
52 Week Range₹18.27 - ₹32.80₹104.00 - ₹419.95
% from 52W High-33.05%-9.79%
All-Time High₹56.56 (Jul 15, 2024)₹419.95 (Nov 12, 2025)
% from All-Time High-61.17%-9.79%
Growth Metrics
Quarterly Revenue Growth1.16%-0.05%
Quarterly Earnings Growth-0.10%N/A
Financial Health
Profit Margin (TTM) i0.03%0.08%
Operating Margin (TTM) i0.06%0.12%
Return on Equity (TTM) i0.10%0.05%
Debt to Equity (MRQ) i131.9321.23
Cash & Liquidity
Book Value per Share (MRQ)₹15.12₹70.98
Cash per Share (MRQ)₹1.76₹0.69
Operating Cash Flow (TTM) i₹-1,276,140,000₹-2,593,269,000
Levered Free Cash Flow (TTM) i₹464.59M₹197.56M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Mukka Proteins Ltd. vs BN Holdings Ltd

MetricMUKKA (Apr 22, 2026)BNHOLDINGS (Nov 13, 2025)
Price Ratios
P/E Ratio (TTM) i15.9526.71
Forward P/E iN/AN/A
PEG Ratio i-1.56-0.13
Price to Sales (TTM) i0.506.91
Price to Book (MRQ) i1.585.01
Market Capitalization
Market Capitalization i₹7.18B₹38.60B
Enterprise Value i₹12.94B₹39.47B
Enterprise Value Metrics
Enterprise to Revenue i0.897.85
Enterprise to EBITDA i11.9171.58
Risk & Other Metrics
Beta i0.170.63
Book Value per Share (MRQ) i₹15.12₹70.98

Financial Statements Comparison: Mukka Proteins Ltd. vs BN Holdings Ltd

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMUKKA (2025)BNHOLDINGS (2025)
Revenue/Sales i9.80B2.99B
Cost of Goods Sold i8.00B2.81B
COGS % of Revenue i81.6%94.0%
Gross Profit i1.80B180.67M
Gross Margin i18.4%6.0%
Research & Development iN/AN/A
Operating Income (EBIT) i815.67M106.15M
Operating Margin i8.3%3.5%
EBITDA i1.00B750.34M
EBITDA Margin i10.2%25.1%
Pre-Tax Income i602.66M216.61M
Pre-Tax Income % of Revenue i6.1%7.2%
Income Tax i121.69M19.06M
Income Tax % of Revenue i1.2%0.6%
Net Income (Profit) i480.97M197.56M
Profit Margin i4.9%6.6%

Balance Sheet & Liquidity Metrics

MetricMUKKA (2025)BNHOLDINGS (2025)
Cash & Equivalents i30.75M67.06M
Total Current Assets i9.26B2.98B
Total Current Assets % of Revenue i94.5%99.7%
Total Current Liabilities i6.10B2.27B
Total Current Liabilities % of Revenue i62.3%75.7%
Long-Term Debt i41.40M439.56M
Long-Term Debt % of Revenue i0.4%14.7%
Total Shareholders Equity i4.57B3.91B
Retained Earnings i2.26B68.92M
Retained Earnings % of Revenue i23.1%2.3%
Property, Plant & Equipment i451.97M12.63M

Cash Flow Statement Comparison

MetricMUKKA (2025)BNHOLDINGS (2025)
Operating Cash Flow i-1.28B-2.59B
Operating Cash Flow % of Revenue i-13.0%-86.6%
Capital Expenditures i-184.38MN/A
Free Cash Flow i-1.39B-315.40M
FCF Margin i-14.2%-10.5%
Debt Repayment iN/AN/A
Common Stock Repurchase i-25.27MN/A

Short Interest & Institutional Ownership Analysis

MetricMUKKABNHOLDINGS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i300.00M97.77M
Float Shares i80.16M42.21M
% Held by Insiders i74.52%77.40%
% Held by Institutions i0.00%18.34%
% Held by Public i25.48%4.26%

Dividend Analysis & Yield Comparison: Mukka Proteins Ltd. vs BN Holdings Ltd

MetricMUKKABNHOLDINGS
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A